rbx7455
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2016 (NCT02981316)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rbx7455
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04155099 | Phase 2 | Dec 31, 2019 | Ochsner Health System, Rebiotix Inc. |
| NCT04139993 | Early Phase 1 (Phase 1) | Oct 31, 2019 | Mayo Clinic, Rebiotix Inc. |
| NCT02981316 | Phase 1 | Nov 1, 2016 | Mayo Clinic, Rebiotix Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Rebiotix Inc. | For profit | 3 | 0 | 2 | 2016 |
| Mayo Clinic | Academic/Hospital | 2 | 2 | 1 | 2016 |
| Ochsner Health System | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1